- Home
- GENI vs RXRX Comparison
GENI vs RXRX Comparison
Compare GENI & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENI
- RXRX
- Stock Information
- Founded
- GENI 2016
- RXRX 2013
- Country
- GENI United Kingdom
- RXRX United States
- Employees
- GENI N/A
- RXRX N/A
- Industry
- GENI Services-Misc. Amusement & Recreation
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- GENI Consumer Discretionary
- RXRX Health Care
- Exchange
- GENI Nasdaq
- RXRX Nasdaq
- Market Cap
- GENI 2.5B
- RXRX 2.2B
- IPO Year
- GENI N/A
- RXRX 2021
- Fundamental
- Price
- GENI $9.92
- RXRX $4.44
- Analyst Decision
- GENI Strong Buy
- RXRX Buy
- Analyst Count
- GENI 17
- RXRX 4
- Target Price
- GENI $13.76
- RXRX $7.25
- AVG Volume (30 Days)
- GENI 6.8M
- RXRX 32.8M
- Earning Date
- GENI 11-04-2025
- RXRX 11-05-2025
- Dividend Yield
- GENI N/A
- RXRX N/A
- EPS Growth
- GENI N/A
- RXRX N/A
- EPS
- GENI N/A
- RXRX N/A
- Revenue
- GENI $604,524,000.00
- RXRX $43,689,000.00
- Revenue This Year
- GENI $28.54
- RXRX $24.17
- Revenue Next Year
- GENI $17.14
- RXRX $20.96
- P/E Ratio
- GENI N/A
- RXRX N/A
- Revenue Growth
- GENI 30.70
- RXRX N/A
- 52 Week Low
- GENI $8.15
- RXRX $3.79
- 52 Week High
- GENI $13.73
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- GENI 44.01
- RXRX 43.73
- Support Level
- GENI $8.59
- RXRX $3.81
- Resistance Level
- GENI $10.51
- RXRX $4.37
- Average True Range (ATR)
- GENI 0.43
- RXRX 0.32
- MACD
- GENI 0.05
- RXRX 0.01
- Stochastic Oscillator
- GENI 69.66
- RXRX 53.91
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.